Suboxone and Methylphenidate drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) and Methylphenidate (methylphenidate). Common drug interactions include abnormal behaviour among females and respiratory depression among males.
The phase IV clinical study analyzes what interactions people have when they take Suboxone and Methylphenidate. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.
What is Suboxone?
Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in opiate withdrawal. eHealthMe is studying from 31,249 Suboxone users. Check the latest studies of Suboxone.
What is Methylphenidate?
Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.
31 people who take Suboxone and Methylphenidate together, and have interactions are studied.

What are the common drug interactions of Suboxone and Methylphenidate, by gender? *:
female:
- Abnormal behaviour
- Disturbance in attention
- Hallucination (an experience involving the perception of something not present)
- Logorrhoea (excessive, uncontrollable, or incoherent talkativeness)
- Pain in extremity
- Skin ulcer
- Arthralgia (joint pain)
- Bladder hypertrophy (bladder overgrowth- increase in cell size)
- Cough
- Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
male:
- Respiratory depression (respiration has a rate below 12 breaths)
- Anxiety
- Bone density decreased
- Fracture
- Osteopenia (a condition where bone mineral density is lower than normal)
- Renal failure (kidney dysfunction)
- Thermal burn (burn by heat)
- Tooth loss
- Acute myocardial infarction (acute heart attack)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
What are the common drug interactions of Suboxone and Methylphenidate, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Agitation (state of anxiety or nervous excitement)
- Anxiety
- Asthenia (weakness)
- Blood pressure increased
- Confusional state
- Decreased appetite
- Depression
- Disturbance in attention
- Dizziness
- Drug dependence
30-39:
n/a
40-49:
- Chronic kidney disease
50-59:
- Respiratory depression (respiration has a rate below 12 breaths)
- Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
- Hyperthermia (body temperature greatly above normal)
- Pulmonary congestion (congestion in the lungs)
- Pulmonary oedema (fluid accumulation in the lungs)
- Abnormal behaviour
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Bone density decreased
- Disturbance in attention
60+:
- Acute myocardial infarction (acute heart attack)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Pain in extremity
- Renal impairment (severely reduced kidney function)
- Skin ulcer
- Vomiting
- Weight decreased
- Chest pain
- Dysarthria (speech disorder)
- Pneumonia legionella (pneumonia caused by the bacteria legionella)
What are the existing conditions these people have? *
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 13 people, 41.94%
- Pain: 8 people, 25.81%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 19.35%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 19.35%
- Hiv Infection: 4 people, 12.90%
- Nausea (feeling of having an urge to vomit): 4 people, 12.90%
- Drowsiness: 4 people, 12.90%
- Depression: 3 people, 9.68%
- Drug Dependence: 3 people, 9.68%
- Stress And Anxiety: 3 people, 9.68%
* Approximation only. Some reports may have incomplete information.
Do you take Suboxone and Methylphenidate?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Suboxone (31,249 reports)
- Methylphenidate (8,216 reports)
Browse all drug interactions of Suboxone and Methylphenidate:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Suboxone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Methylphenidate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Suboxone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Methylphenidate and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on buprenorphine hydrochloride; naloxone hydrochloride and methylphenidate (the active ingredients of Suboxone and Methylphenidate, respectively), and Suboxone and Methylphenidate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cannabis cause Nausea Aggravated? - 8 seconds ago
- Could Alendronate Sodium cause Abnormal Loss Of Weight? - 28 seconds ago
- Drug interactions of Androgel and Axid - 44 seconds ago
- Could Neosporin cause Numbness And Tingling? - 46 seconds ago
- Could Valproate Sodium cause Humerus Fracture? - 47 seconds ago
- Drug interactions of Insulin and Mavik - 51 seconds ago
- Drug interactions of Probiotic and Revatio - 55 seconds ago
- Drug interactions of Pred Forte and Ondansetron - a minute ago
- Could Quetiapine Fumarate cause Muscle Spasticity Aggravated? - a minute ago
- Drug interactions of Relpax and Reglan - a minute ago